Selective Estrogen Receptor Modulators (SERMs) undoubtedly are a cornerstone of pharmaceutical PCT interventions. They operate as aggressive inhibitors at estrogen receptors from the hypothalamus although exhibiting tissue-selective agonist or antagonist properties through the entire entire body. SERMs are crucial in regulating post cycle estrogen